Immune Control
Immune Control a Conshohocken, Pa-based drug company focused on the treatment of multiple myeloma and other immunological diseases.
HQ location
Conshohocken, United States
Website
Launch date
Enterprise value
$45—68m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
BioAdvance(exited)
Domain Associates(exited)
Anthem Capital Management(exited)
NewSpring Capital(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads